Use of an Ultra-rapid BRCA1/2 Status Screening Test in Diagnostic and Theranostic Indication: Performance and Interest for Patients and Practitioners

NCT06111417 · clinicaltrials.gov ↗

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

OTHER: Questionnaires
OTHER: Communication of the results of the BRCA1/2 ultra rapid test

Sponsor

Centre Georges Francois Leclerc